FY2024 EPS Estimates for Vivani Medical Cut by HC Wainwright

Vivani Medical, Inc. (NASDAQ:VANI) – Analysts at HC Wainwright lowered their FY2024 earnings estimates for Vivani Medical in a research report issued to clients and investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.43) per share for the year, down from their previous forecast of ($0.41). HC Wainwright has a “Buy” rating and a $4.00 price objective on the stock. The consensus estimate for Vivani Medical’s current full-year earnings is ($0.41) per share. HC Wainwright also issued estimates for Vivani Medical’s Q1 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.39) EPS.

Vivani Medical Trading Up 0.9 %

Shares of VANI stock opened at $1.10 on Monday. The firm’s fifty day simple moving average is $1.16 and its 200 day simple moving average is $1.22. The firm has a market capitalization of $65.16 million, a P/E ratio of -2.44 and a beta of 3.20. Vivani Medical has a 1 year low of $1.03 and a 1 year high of $2.22.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC acquired a new stake in Vivani Medical during the 4th quarter valued at $66,000. Wealthedge Investment Advisors LLC acquired a new position in Vivani Medical during the 4th quarter valued at about $43,000. Geode Capital Management LLC lifted its position in Vivani Medical by 4.6% during the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock valued at $401,000 after purchasing an additional 15,008 shares during the period. Finally, Northern Trust Corp boosted its stake in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after purchasing an additional 11,540 shares during the last quarter. 6.78% of the stock is currently owned by institutional investors and hedge funds.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.